Glanders, melioidosis and biowarfare;Morve, mélioïdose et bioterrorisme

Presse Medicale

Volumn 34, Issue 2 II, 2005, Pages 185-188

  Guilhot, Amélie ^a   Bricaire, François ^a   Bossi, Philippe ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; COTRIMOXAZOLE; DOXYCYCLINE; IMIPENEM; MEROPENEM;

AEROSOL; BIOLOGICAL WARFARE; BURKHOLDERIA MALLEI; BURKHOLDERIA PSEUDOMALLEI; CHILD; CLINICAL FEATURE; DISEASE SEVERITY; ENDEMIC DISEASE; EUROPE; EXPOSURE; HORSE DISEASE; HUMAN; INFANT; LETHARGY; LUNG TUBERCULOSIS; MELIOIDOSIS; NONHUMAN; PRACTICE GUIDELINE; PROPHYLAXIS; REVIEW; SEPTICEMIA; TROPICS;

EID: 13244253706     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0755-4982(05)83900-4     Document Type: Review

References (13)

1. Franz D, Jahrling P, Friedlander A et al. Clinical recognition and management of patients exposed to biological warfare agents. JAMA 1997; 278: 399-411.
2. Kasten FH. Biological weapons, war crimes, and WWI. Science 2002; 296: 1235-7.
3. Anuntagool N, Sirisinha S. Antigenic relatedness between Burkholderia pseudomallei and Burkholderia mallei. Microbiol Immunol 2002; 46: 143-50.
4. Rosenbloom M, Leikin JB, Vogel SN, Chaudry ZA. Biological and chemical agents: a brief synopsis. Am J Ther 2002; 9: 5-14.
5. Srinivasan A, Kraus CN, DeShazer D et al. Glanders in a military research microbiologist. N Engl J Med 2001; 345: 256-8.
6. Yang S. Melioidosis research in China. Acta Trop 2000; 77: 157-65.
7. Laboratory-acquired human glanders-Maryland, May 2000. MMWR Morb Mortal Wkly Rep 2000; 49: 532-5.
8. Godoy D, Randle G, Simpson AJ et al. Multilocus sequence typing and evolutionary relationships among the causative agents of melioidosis and glanders, Burkholderia pseudomallei and Burkholderia mallei. J Clin Microbiol 2003; 41: 2068-79.
9. Gee JE, Sacchi CT, Glass MB et al. Use of 16S rRNA gene sequencing for rapid identification and differentiation of Burkholderia pseudomallei and B. mallei. J Clin Microbiol 2003; 41: 4647-54.
10. Heine HS, England MJ, Waag DM, Byrne WR. In vitro antibiotic susceptibilities of Burkholderia mallei (causative agent of glanders) determined by broth microdilution and E-test. Antimicrob Agents Chemother 2001; 45: 2119-21.
11. Russell P, Eley SM, Ellis J et al. Comparison of efficacy of ciprofloxacin and doxycycline against experimental melioidosis and glanders. J Antimicrob Chemother 2000; 45: 813-8.
12. Kenny D, Russell P, Rogers D, Eley S, Titball R. In vitro susceptibilities of Burkholderia mallei in comparison to those of other pathogenic Burkholderia spp. Antimicrob Agents Chemother 1999; 43: 2773-5.
13. The European Agency for the Evaluation of Medicinal Products/CPMP guidance document on use of medicinal products for treatment and prophylaxis of biological agents that might be used as weapons of bioterrorism. July 2002; www.emea.eu.int.